Cargando…

Risk of malignancy in patients with chronic kidney disease

BACKGROUND: Fifteen percent of US adults have chronic kidney disease (CKD). The effect of CKD on the development of different malignancies is unknown. Understanding the effect of CKD on the risk of development of cancer could have important implications for screening and early detection of cancer in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tendulkar, Ketki K., Cope, Brendan, Dong, Jianghu, Plumb, Troy J., Campbell, W. Scott, Ganti, Apar Kishor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385037/ https://www.ncbi.nlm.nih.gov/pubmed/35976968 http://dx.doi.org/10.1371/journal.pone.0272910

Ejemplares similares

Hepatitis B Vaccination in Advanced Chronic Kidney Disease: A Quality Improvement Project at a Veteran Affairs Chronic Kidney Disease Clinic
por: Hettenbaugh, Jacob, et al.
Publicado: (2021)

Pembrolizumab—the “KEY” to an evolving landscape in treatment of squamous non-small cell lung cancer (NSCLC)
por: Yellala, Amulya, et al.
Publicado: (2020)

Cisplatin or carboplatin for advanced non-small cell lung cancer: does it really matter?
por: Kesireddy, Meghana, et al.
Publicado: (2021)

Promising trends in lung cancer care, but are we overlooking the majority?
por: Sharma, Bhavina, et al.
Publicado: (2023)

Clinical Utility of Mobocertinib in the Treatment of NSCLC – Patient Selection and Reported Outcomes
por: Arnold, Abram, et al.
Publicado: (2023)

EGFR targeted therapy in non-small cell lung cancer: potential role of cetuximab
por: Reade, Chad A, et al.
Publicado: (2009)

Current concepts in the management of small cell lung cancer
por: Ganti, Apar Kishor, et al.
Publicado: (2013)

Profile of vismodegib and its potential in the treatment of advanced basal cell carcinoma
por: Macha, Muzafar A, et al.
Publicado: (2013)

Impact of time-to-treatment on overall survival of non-small cell lung cancer patients—an analysis of the national cancer database
por: Anggondowati, Trisari, et al.
Publicado: (2020)

Pancytopenia due to iron deficiency worsened by iron infusion: a case report
por: Ganti, Apar Kishor, et al.
Publicado: (2007)

Systemic inflammation is associated with inferior disease control and survival in stage III non-small cell lung cancer
por: Keit, Emily, et al.
Publicado: (2021)

Exertional Chest Pain and Dyspnea From Hyperviscosity Syndrome Related to Marginal Zone Lymphoma
por: Dhakal, Prajwal, et al.
Publicado: (2014)

Risk factors of SARS-CoV-2 infection and complications from COVID-19 in lung cancer patients
por: Ganti, Apar Kishor, et al.
Publicado: (2023)

Real-world management of patients with epidermal growth factor receptor (EGFR) mutation-positive non–small-cell lung cancer in the USA
por: Li, Yulin, et al.
Publicado: (2019)

Correction: Real-world management of patients with epidermal growth factor receptor (EGFR) mutation-positive non-small-cell lung cancer in the USA
por: Li, Yulin, et al.
Publicado: (2019)

Characterizing Immune Checkpoint Inhibitor-Induced Hypophysitis and Obstacles in Diagnosis
por: Johnson, Jake, et al.
Publicado: (2021)

Weight Loss and Percutaneous Endoscopic Gastrostomy Tube Placement during Chemoradiotherapy for Locally Advanced Cancer of the Oropharynx Do Not Negatively Impact Outcomes
por: Baine, Michael J., et al.
Publicado: (2017)

HER-2/neu and CD117 (c-kit) overexpression in patients with pesticide exposure and extensive stage small cell lung carcinoma (ESSCLC)
por: Potti, Anil, et al.
Publicado: (2005)

Characteristics of toxicity occurrence patterns in concurrent chemoradiotherapy after induction chemotherapy for patients with locally advanced non-small cell lung cancer: a pooled analysis based on individual patient data of CALGB/Alliance trials
por: Yang, Lexie Zidanyue, et al.
Publicado: (2022)

Real‐world outcomes of anti‐EGFR therapy in advanced non–small cell lung cancer EGFR mutated in Peru
por: Galvez‐Nino, Marco, et al.
Publicado: (2022)

The incidence of and risk factors for late presentation of childhood chronic kidney disease: A systematic review and meta-analysis
por: Plumb, Lucy, et al.
Publicado: (2020)

RNA-based therapies: A cog in the wheel of lung cancer defense
por: Khan, Parvez, et al.
Publicado: (2021)

Recurrent Cushing Syndrome Secondary to Metastatic Adrenocortical Carcinoma in a Patient With Previously Resected Adenoma
por: Addasi, Noor, et al.
Publicado: (2021)

Recurrent Cushing Syndrome From Metastatic Adrenocortical Carcinoma With Fumarate Hydratase Allelic Variant
por: Silverman, Emily, et al.
Publicado: (2022)

Validation of Progression‐Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials
por: Wang, Xiaofei, et al.
Publicado: (2017)

Kidney Stones and Risk of Osteoporotic Fracture in Chronic Kidney Disease
por: Han, Seung Gyu, et al.
Publicado: (2019)

Mesenteric panniculitis: systematic review of cross-sectional imaging findings and risk of subsequent malignancy
por: Halligan, Steve, et al.
Publicado: (2016)

Chimeric antibody targeting unique epitope on onco-mucin16 reduces tumor burden in pancreatic and lung malignancies
por: Shah, Ashu, et al.
Publicado: (2023)

Plant-based dietary approach to stage 3 chronic kidney disease with hyperphosphataemia
por: Campbell, Thomas M, et al.
Publicado: (2019)

Perceptions of prognostic risks in chronic kidney disease: a national survey
por: Chiu, Helen H. L., et al.
Publicado: (2015)

Risk of falls in chronic kidney disease
por: Papakonstantinopoulou, Konstantina, et al.
Publicado: (2017)

Achieving Salt Restriction in Chronic Kidney Disease
por: McMahon, Emma J., et al.
Publicado: (2012)

The cost-effectiveness of using chronic kidney disease risk scores to screen for early-stage chronic kidney disease
por: Yarnoff, Benjamin O., et al.
Publicado: (2017)

Influence of chronic kidney disease and other risk factors pre-heart transplantation on malignancy incidence post-heart transplantation
por: Roest, Stefan, et al.
Publicado: (2023)

Anemia and risk for cognitive decline in chronic kidney disease
por: Kurella Tamura, Manjula, et al.
Publicado: (2016)

Risk factors for chronic kidney disease: an update
por: Kazancioğlu, Rumeyza
Publicado: (2013)

The risk of atherosclerosis in patients with chronic kidney disease
por: Olechnowicz-Tietz, Sylwia, et al.
Publicado: (2013)

Modulation of stroke risk in chronic kidney disease
por: Arnold, Julia, et al.
Publicado: (2016)

10. Cardiovascular Risk in Chronic Kidney Disease
por: Lainščak, Mitja
Publicado: (2009)

Long-term lithium therapy and risk of chronic kidney disease, hyperparathyroidism and hypercalcemia: a cohort study
por: Boivin, Elise, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pln16eg7h4ud1ttrbu8q0f39b6